Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 9 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• HHHFA in COPD Patients, With Chronic BronchitisCompletedNCT03959982Not applicableResults posted
• Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)CompletedNCT03954132Results posted
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationCompletedNCT03930732Phase 3Results posted
• Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)CompletedNCT03888131Phase 3Results posted
• Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease PatientsTerminatedNCT03851510Results posted
• A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus SecretionsCompletedNCT03843541Phase 3Results posted
• A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCompletedNCT03836677Phase 3Results posted
• A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With EosinophiliaTerminatedNCT03810183Phase 2Results posted
• COPD Access to Pulmonary Rehabilitation InterventionCompletedNCT03794921Not applicableResults posted
• Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)TerminatedNCT03794583Phase 3Results posted
• Residential Cleaning of Indoor Air to Protect COPD PatientsCompletedNCT03750292Not applicableResults posted
• Effectiveness of Triple Therapy in COPDCompletedNCT03724877Results posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• Pulmonary Specialist-Health Coach Consult Model StudyCompletedNCT03695276Not applicableResults posted
• Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin DeficiencyCompletedNCT03679598Phase 2Results posted
• A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerCompletedNCT03663569Results posted
• Motivational Interviewing and Air Cleaners for Smokers With COPD (MOVE COPD)CompletedNCT03658538Not applicableResults posted
• RESP-FIT: Technology-Enhanced Self-Management in COPDCompletedNCT03652662Not applicableResults posted
• Metformin to Reduce Airway Glucose in COPD PatientsCompletedNCT03651895Phase 2Results posted
• A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.CompletedNCT03645434Phase 2Results posted
• Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP)CompletedNCT03615040Phase 2Results posted
• The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.CompletedNCT03611777Results posted
• The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)CompletedNCT03583099Not applicableResults posted
• A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPDCompletedNCT03573817Phase 3Results posted
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03546907Phase 2Results posted
• Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of IllnessCompletedNCT03543176Results posted
• Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)TerminatedNCT03513068Not applicableResults posted
• A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03496623Phase 3Results posted
• Home Pulmonary Rehabilitation for COPDCompletedNCT03480386Not applicableResults posted
• A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03478696Phase 4Results posted
• A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03478683Phase 4Results posted
• A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03474081Phase 4Results posted
• INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignCompletedNCT03467425Phase 4Results posted
• GSK1325756 Relative Bioavailability Study in Healthy Elderly SubjectsCompletedNCT03457727Phase 1Results posted
• Capnometry-Assisted Breathing Training for COPDCompletedNCT03457103Phase 2Results posted
• Integrated Care (IC) Models for Patient-Centered OutcomesCompletedNCT03451630Not applicableResults posted
• Monitoring and Peer Support to Improve Treatment Adherence and OutcomesCompletedNCT03446768Not applicableResults posted
• Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric SurgeryCompletedNCT03438383Not applicableResults posted
• Greek NIS Spiolto ELLACTOCompletedNCT03419962Results posted
• Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 AgonistsCompletedNCT03405363Results posted
• Peripheral Nerve Blocks for Above-the-knee AmputationsCompletedNCT03404180Phase 4Results posted
• A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of NemiralisibCompletedNCT03398421Phase 1Results posted
• Acupuncture Treatment of Chronic Obstructive Pulmonary Disease (COPD) ExacerbationCompletedNCT03398213Not applicableResults posted
• A Randomized Study to Evaluate the Effect of Reminder Notifications and Motivational/Adaptive Messaging on Treatment AdherenceTerminatedNCT03379233Phase 3Results posted
• Comparative Effectiveness of COPD TreatmentsCompletedNCT03376295Results posted
• Sensor and Electronic Health Records (EHR) Integration Pilot StudyCompletedNCT03357341Results posted
• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03345407Phase 2Results posted
• Absorption & Elimination of Radiolabelled GSK2269557CompletedNCT03315559Phase 1Results posted
• A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010CompletedNCT03311373Phase 1Results posted
• Immunization To Prevent Acute COPD ExacerbationsTerminatedNCT03276754Results posted
• Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT03276078Phase 2Results posted
• Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]CompletedNCT03265145Phase 4Results posted
• Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03256695Phase 3Results posted
• Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPDCompletedNCT03256552Phase 2Results posted
• Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03250689Phase 2Results posted
• A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat DoseCompletedNCT03250182Phase 1Results posted
• Belimumab Treatment of Emphysema Patients With Anti-GRP78 AutoantibodiesCompletedNCT03244059Phase 2Results posted
• The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusCompletedNCT03240575Phase 4Results posted
• Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the DrugCompletedNCT03235726Phase 1Results posted
• Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03227445Phase 4Results posted
• Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD OutpatientsCompletedNCT03221387Not applicableResults posted
• Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03219866Phase 4Results posted
• An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPDCompletedNCT03207776Not applicableResults posted
• Active for Life: Chronic Obstructive Pulmonary DiseaseCompletedNCT03201198Not applicableResults posted
• Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)CompletedNCT03197818Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy SubjectsCompletedNCT03189589Phase 1Results posted
• A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03170232Phase 2Results posted
• Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)CompletedNCT03165045Results posted
• Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT03162055Phase 3Results posted
• Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT03159091Phase 4Results posted
• Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia PacificCompletedNCT03151395Not applicableResults posted
• Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device RobustnessCompletedNCT03137992Phase 3Results posted
• Study of Danirixin in Japanese Healthy Elderly Male SubjectsCompletedNCT03136380Phase 1Results posted
• Expanding Access to Home-Based Palliative CareTerminatedNCT03128060Not applicableResults posted
• Effects of Remote Patient Monitoring on Chronic Disease ManagementCompletedNCT03127852Not applicableResults posted
• Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03118765Phase 2Results posted
• Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIsCompletedNCT03114969Results posted
• Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPDCompletedNCT03095456Phase 3Results posted
• Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPDCompletedNCT03094806Not applicableResults posted
• Smart Telehealth Exercise Intervention to Reduce COPD ReadmissionsCompletedNCT03089853Not applicableResults posted
• The Topic Trial - Study to Determine the Safety and Efficacy of IvacaftorCompletedNCT03085485Phase 2Results posted
• A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT03084796Phase 2Results posted
• The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPDCompletedNCT03081156Phase 4Results posted
• Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult SubjectsCompletedNCT03075267Phase 1Results posted
• Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03064113Phase 2Results posted
• Cardiovascular Function in COPD PatientsCompletedNCT03055988Phase 4Results posted
• Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03034967Phase 2Results posted
• A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03034915Phase 4Results posted
• Drug Utilization Study for OlodaterolCompletedNCT03030638Results posted
• The Effects of RPL554 in Addition to Tiotropium in COPD PatientsCompletedNCT03028142Phase 2Results posted
• Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin DeficiencyCompletedNCT03008915Phase 2Results posted
• Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - ItalyCompletedNCT03003494Results posted
• A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02982187Phase 4Results posted
• Imaging of Peri-operative (periOP) Lung InjuryTerminatedNCT02978885Phase 2Results posted
• Lung Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT02978144Phase 2Results posted
• Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871CompletedNCT02971293Phase 2Results posted
• Chronic Obstructive Pulmonary Disease Patient Preferences SurveyCompletedNCT02970422Results posted
• Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsCompletedNCT02969317Phase 1Results posted
• Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy VolunteersCompletedNCT02968914Phase 1Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02951312Phase 2Results posted

← Pulmonary Disease, Chronic Obstructive overview